Assessing Mass Photometry as a Robust Method for Characterizing Adeno-Associated Virus Critical Quality Attributes in Gene Therapy Vector

分享:

简介:

论文中使用的产品/服务

询价

摘要

The use of adeno-associated viruses (AAVs) as gene therapy vectors is growing, resulting in a pressing need for efficient, reliable AAV analysis methods. Characterizing AAV critical quality attributes (CQAs), such as the abundance of empty or partially filled capsids, is paramount for developing and producing products with high efficacy, low immunogenicity, and low cost. Available methods include analytical ultracentrifugation (AUC)—considered one of the gold standards of AAV analysis technique—and mass photometry—a newer method based on single-particle light scattering. Mass photometry is a fast, low-cost tool that uses little sample and is suitable for environments requiring good manufacturing practices (GMP) compliance. Here, we assess mass photometry’s performance in AAV characterization by using it to analyze a sample of empty AAVs, to measure proportions of empty vs. partially filled vs. full AAVs, to quantify loading in samples ranging from 100% empty to nearly 100% loaded, and to measure samples containing transgenes of different lengths. Comparing to AUC data where appropriate, we find that the two methods give comparable results. Based on its accuracy, precision, measurement capabilities, and practical advantages (e.g., speed and low cost), we conclude that mass photometry is an ideal AAV analysis tool.

关于派真

作为一家专注于AAV 技术十余年,深耕基因治疗领域的CRO&CDMO,派真生物可提供从载体设计、构建到 AAV、慢病毒和 mRNA 服务的一站式解决方案。凭借深厚的技术实力、卓越的运营管理和高标准的服务交付,我们为全球客户提供一站式CMC解决方案,包括从早期概念验证、成药性评估到IITINDBLA的各个阶段。

 

凭借我们独立知识产权的π-alphaTM 293 细胞AAV高产技术平台,我们能将AAV产量提高多至10倍,每批次产量可达1×10¹⁷vg,以满足多样化的商业化和临床项目需求。此外,我们定制化的mRNA和脂质纳米颗粒(LNP)产品及服务覆盖药物和疫苗开发的各个阶段,从研发到符合GMP的生产,提供端到端的一站式解决方案。

下载

用户登录

还没账号? 请注册
手机验证码登录
账号密码登录
手机号码*
验证码*
忘记密码?

首次使用手机号登录将自动为您注册

登录即代表阅读并接受《注册协议》 《用户协议》

新用户注册

已有账号?
手机注册
邮箱注册
手机号码*
验证码*
机构名称*
客户类型*

重置密码

手机找回密码
邮箱找回密码
手机号码*
验证码*
设置新密码*
确认新密码*